Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData’s new report, “Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global Point of Care (POC) diagnostics market. The report provides market landscape, competitive landscape and market trends information on the POC diagnostics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, and Japan.

- Key segments covered include Clinical Chemistry, Immuno Chemistry and Hematology.

- Annualized market revenues data from forecast forward for seven years to 2018. Company shares data for 2011.

- Qualitative analysis of key market trends, market drivers, and restraints within point of care diagnostics market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include F. Hoffmann-La Roche Ltd., Alere, Inc., Siemens Healthcare and Abbott Laboratories.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the POC diagnostics market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.

- What’s the next big thing in the POC diagnostics market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global POC diagnostics market and the factors shaping it.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Point-of-Care Diagnostics - Introduction 7

2.1 GlobalData Report Guidance 7

3 Device Overview - Point-of-Care Diagnostics 8

4 PoC Diagnostics - Market Characterization 10

4.1 Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011–2018 10

4.2 Clinical Chemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018 11

4.3 Immunochemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018 12

4.4 Hematology Point-of-Care Diagnostics Market, Global, Revenue ($m), Forecast, 2011-2018 13

4.5 PoC Diagnostics, Market Trends 14

4.5.1 Integration of Results from Point-of-Care Testing with Electronic Medical Records on the Rise 14

4.5.2 Trend towards Increase in the Share of Point-of-Care Testing Within In Vitro Diagnostics 15

4.5.3 Growth in the Adoption of Molecular Diagnostics for Point-of-Care Testing is Expected 16

4.6 PoC Diagnostics, Market Dynamics 17

4.6.1 Market Drivers 17

4.6.2 Market Restraints 22

5 Point-of-Care Diagnostics Market, by Country, Revenue ($m), 2011–2018 23

5.1 Point-of-Care Diagnostics Market, The US, Revenue ($m), Forecast, 2011–2018 23

5.2 Clinical Chemistry PoC Diagnostics Market, The US, Revenue ($m), Forecast, 2011–2018 24

5.3 Immunochemistry PoC Diagnostics Market, The US, Revenue ($m), Forecast, 2011–2018 25

5.4 Hematology PoC Diagnostics Market, The US, Revenue ($m), Forecast, 2011–2018 26

5.5 Point-of-Care Diagnostics Market, Canada, Revenue ($m), Forecast, 2011–2018 27

5.6 Clinical Chemistry PoC Diagnostics Market, Canada, Revenue ($m), Forecast, 2011–2018 28

5.7 Immunochemistry PoC Diagnostics Market, Canada, Revenue ($m), Forecast, 2011–2018 29

5.8 Hematology PoC Diagnostics Market, Canada, Revenue ($m), Forecast, 2011–2018 30

5.9 Point-of-Care Diagnostics Market, The UK, Revenue ($m), Forecast, 2011–2018 31

5.10 Clinical Chemistry PoC Diagnostics Market, The UK, Revenue ($m), Forecast, 2011–2018 32

5.11 Immunochemistry PoC Diagnostics Market, The UK, Revenue ($m), Forecast, 2011–2018 33

5.12 Hematology PoC Diagnostics Market, The UK, Revenue ($m), Forecast, 2011–2018 34

5.13 Point-of-Care Diagnostics Market, Germany, Revenue ($m), Forecast, 2011–2018 35

5.14 Clinical Chemistry PoC Diagnostics Market, Germany, Revenue ($m), Forecast, 2011–2018 36

5.15 Immunochemistry PoC Diagnostics Market, Germany, Revenue ($m), Forecast, 2011–2018 37

5.16 Hematology PoC Diagnostics Market, Germany, Revenue ($m), Forecast, 2011–2018 38

5.17 Point-of-Care Diagnostics Market, France, Revenue ($m), Forecast, 2011–2018 39

5.18 Clinical Chemistry PoC Diagnostics Market, France, Revenue ($m), Forecast, 2011–2018 40

5.19 Immunochemistry PoC Diagnostics Market, France, Revenue ($m), Forecast, 2011–2018 41

5.20 Hematology PoC Diagnostics Market, France, Revenue ($m), Forecast, 2011–2018 42

5.21 Point-of-Care Diagnostics Market, Italy, Revenue ($m), Forecast, 2011–2018 43

5.22 Clinical Chemistry PoC Diagnostics Market, Italy, Revenue ($m), Forecast, 2011–2018 44

5.23 Immunochemistry PoC Diagnostics Market, Italy, Revenue ($m), Forecast, 2011–2018 45

5.24 Hematology PoC Diagnostics Market, Italy, Revenue ($m), Forecast, 2011–2018 46

5.25 Point-of-Care Diagnostics Market, Spain, Revenue ($m), Forecast, 2011–2018 47

5.26 Clinical Chemistry PoC Diagnostics Market, Spain, Revenue ($m), Forecast, 2011–2018 48

5.27 Immunochemistry PoC Diagnostics Market, Spain, Revenue ($m), Forecast, 2011–2018 49

5.28 Hematology PoC Diagnostics Market, Spain, Revenue ($m), Forecast, 2011–2018 50

5.29 Point-of-Care Diagnostics Market, Japan, Revenue ($m), Forecast, 2011–2018 51

5.30 Clinical Chemistry PoC Diagnostics Market, Japan, Revenue ($m), Forecast, 2011–2018 52

5.31 Immunochemistry PoC Diagnostics Market, Japan, Revenue ($m), Forecast, 2011–2018 53

5.32 Hematology PoC Diagnostics Market, Japan, Revenue ($m), Forecast, 2011–2018 54

6 Point-of-Care Diagnostics Market - Strategic Competitive Assessment 55

6.1 Point-of-Care Diagnostics Market, Global, Key Company Share (%), 2011 55

6.2 PoC Diagnostics, Market Opportunities and Risk Evaluation 56

6.2.1 Opportunities Assessment 57

6.2.2 Risk Evaluation 58

6.3 PoC Diagnostics, Key Market Participants 59

6.3.1 Alere, Inc 59

6.3.2 La Hoffmann Roche, Inc. 62

6.3.3 Siemens Healthcare Diagnostics 65

6.3.4 Abbott Laboratories 68

7 Point-of-Care Diagnostics Market - Strategic Pipeline Assessment 71

7.1 PoC Diagnostics: Product Pipeline Analysis 71

7.2 PoC Diagnostics, List of Pipeline Products 72

7.3 PoC Diagnostics: Profiles of Key Products under Clinical Development 74

7.3.1 Cerebrostrip Diagnostic Test 74

7.3.2 Osmo POC Dehydration Diagnostic System 74

7.3.3 WOUNDCHEK Protease Status 74

7.3.4 Preterm Birth Prediction Test 75

7.3.5 Point-of-Care Rapid Portable Biosensor 75

7.3.6 Point-of-Care Testing Device 76

7.3.7 POC Screening Device - Dyssynergic Defecation 76

7.3.8 Point-Of-Care Dipstick Test - Acetaminophen-Induced Liver Injury 77

8 Point-of-Care Diagnostics Market - Key Mergers and Acquisitions (2011) 78

8.1 Modern Mobility Aids Finalizes Acquisition of LumiGene Technologies 78

8.1.1 Overview 78

8.1.2 Deal Rationale 78

8.2 Opko Health Acquires Claros Diagnostics 78

8.2.1 Overview 78

8.2.2 Deal Rationale 78

8.3 Sony Acquires Micronics 78

8.3.1 Overview 78

8.3.2 Deal Rationale 78

8.4 EKF Diagnostics Completes Acquisition of Stanbio Laboratory 79

8.4.1 Overview 79

8.4.2 Deal Rationale 79

8.5 CerMed International Acquires Viridis Bioscience 79

8.5.1 Overview 79

8.5.2 Deal Rationale 79

9 Appendix 80

9.1 Definitions 81

9.1.1 PoC Diagnostics 81

9.2 Acronyms 82

9.3 Sources 83

9.4 Research Methodology 84

9.5 Secondary Research 84

9.6 Primary Research 84

9.7 Models 85

9.8 Forecasts 85

9.9 Expert Panels 85

9.10 GlobalData Consulting 85

9.11 Contact Us 86

9.12 Disclaimer 86

1.1 List of Tables

Table 1: Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 10

Table 2: Clinical Chemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 11

Table 3: Immunochemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 12

Table 4: Hematology Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 13

Table 5: Electronic Medical Records Market, Global, Revenue ($bn), Forecast, 2011-2018 14

Table 6: Percentage Adoption of Point-of-Care Testing and Centralized Laboratory Testing, Global, 2011-2018 15

Table 7: Molecular Diagnostics Market, Global, Revenue ($bn), Forecast, 2011–2015 16

Table 8: Vacancy Rates by Department in Clinical Laboratories, The US, 2011 18

Table 9: New Product Launches, 2011 19

Table 10: Percentage of People Aged 65 Years and Above in the Total Adult Population, by Country, %, 1980-2050 21

Table 11: Point-of-Care Diagnostics Market, The US, Revenue ($m), 2011-2018 23

Table 12: Clinical Chemistry PoC Diagnostics Market, The US, Revenue ($m), 2011-2018 24

Table 13: Immunochemistry PoC Diagnostics Market, The US, Revenue ($m), 2011-2018 25

Table 14: Hematology PoC Diagnostics Market, The US, Revenue ($m), 2011-2018 26

Table 15: Point-of-Care Diagnostics Market, Canada, Revenue ($m), 2011-2018 27

Table 16: Clinical Chemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018 28

Table 17: Immunochemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018 29

Table 18: Hematology PoC Diagnostics Market, Canada, Revenue ($m), 2011-2018 30

Table 19: Point-of-Care Diagnostics Market, The UK, Revenue ($m), 2011-2018 31

Table 20: Clinical Chemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018 32

Table 21: Immunochemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018 33

Table 22: Hematology PoC Diagnostics Market, The UK, Revenue ($m), 2011-2018 34

Table 23: Point-of-Care Diagnostics Market, Germany, Revenue ($m), 2011-2018 35

Table 24: Clinical Chemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018 36

Table 25: Immunochemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018 37

Table 26: Hematology PoC Diagnostics Market, Germany, Revenue ($m), 2011-2018 38

Table 27: Point-of-Care Diagnostics Market, France, Revenue ($m), 2011-2018 39

Table 28: Clinical Chemistry PoC Diagnostics Market, France, Revenue ($m), 2011-2018 40

Table 29: Immunochemistry PoC Diagnostics Market, France, Revenue ($m), 2011-2018 41

Table 30: Hematology PoC Diagnostics Market, France, Revenue ($m), 2011-2018 42

Table 31: Point-of-Care Diagnostics Market, Italy, Revenue ($m), 2011-2018 43

Table 32: Clinical Chemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018 44

Table 33: Immunochemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018 45

Table 34: Hematology PoC Diagnostics Market, Italy, Revenue ($m), 2011-2018 46

Table 35: Point-of-Care Diagnostics Market, Spain, Revenue ($m), 2011-2018 47

Table 36: Clinical Chemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018 48

Table 37: Immunochemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018 49

Table 38: Hematology PoC Diagnostics Market, Spain, Revenue ($m), 2011-2018 50

Table 39: Point-of-Care Diagnostics Market, Japan, Revenue ($m), 2011-2018 51

Table 40: Clinical Chemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018 52

Table 41: Immunochemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018 53

Table 42: Hematology PoC Diagnostics Market, Japan, Revenue ($m), 2011-2018 54

Table 43: Point-of-Care Diagnostics Market, Global, Key Company Revenue ($m), 2011 55

Table 44: Alere, Point-of-Care Diagnostics, Key Marketed Products 59

Table 45: Examples of Companies Acquired by Alere 61

Table 46: Roche, PoC Diagnostics, Key Marketed Products 62

Table 47: Siemens Healthcare, Point-of-Care Testing, Key Marketed Products 65

Table 48: Abbott Diagnostics, PoC Diagnostics, Key Marketed Products 68

Table 49: Pipeline Technology Assessment for PoC Diagnostics, Global, I 72

Table 50: Pipeline Technology Assessment for PoC Diagnostics, Global, II 73

Table 51: Cerebrostrip Diagnostic Test, Product Status 74

Table 52: Osmo POC Dehydration Diagnostic System, Product Status 74

Table 53: WOUNDCHEK Protease Status, Product Status 74

Table 54: Preterm Birth Prediction Test, Product Status 75

Table 55: Point-of-Care Rapid Portable Biosensor, Product Status 75

Table 56: Point-of-Care Testing Device, Product Status 76

Table 57: POC Screening Device - Dyssynergic Defecation, Product Status 76

Table 58: Point-Of-Care Dipstick Test - Acetaminophen-Induced Liver Injury, Product Status 77

1.2 List of Figures

Figure 1: Point-of-Care Diagnostics, Market Segmentation 8

Figure 2: Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 10

Figure 3: Clinical Chemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 11

Figure 4: Immunochemistry Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 12

Figure 5: Hematology Point-of-Care Diagnostics Market, Global, Revenue ($m), 2011-2018 13

Figure 6: Electronic Medical Records Market, Global, Revenue ($bn), Forecast, 2011-2018 14

Figure 7: Percentage Adoption of Point-of-Care Testing and Centralized Laboratory Testing, Global, 2011-2018 15

Figure 8: Molecular Diagnostics Market, Global, Revenue ($bn), Forecast, 2011–2015 16

Figure 9: Vacancy Rates by Department in Clinical Laboratories, The US, 2011 18

Figure 10: Percentage of People Aged 65 Years and Above in the Total Adult Population, by Country, %, 1980–2050 20

Figure 11: Point-of-Care Diagnostics Market, The US, Revenue ($m), 2011–2018 23

Figure 12: Clinical Chemistry PoC Diagnostics Market, The US, Revenue ($m), 2011–2018 24

Figure 13: Immunochemistry PoC Diagnostics Market, The US, Revenue ($m), 2011–2018 25

Figure 14: Hematology PoC Diagnostics Market, The US, Revenue ($m), 2011–2018 26

Figure 15: Point-of-Care Diagnostics Market, Canada, Revenue ($m), 2011–2018 27

Figure 16: Clinical Chemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011–2018 28

Figure 17: Immunochemistry PoC Diagnostics Market, Canada, Revenue ($m), 2011–2018 29

Figure 18: Hematology PoC Diagnostics Market, Canada, Revenue ($m), 2011–2018 30

Figure 19: Point-of-Care Diagnostics Market, The UK, Revenue ($m), 2011–2018 31

Figure 20: Clinical Chemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011–2018 32

Figure 21: Immunochemistry PoC Diagnostics Market, The UK, Revenue ($m), 2011–2018 33

Figure 22: Hematology PoC Diagnostics Market, The UK, Revenue ($m), 2011–2018 34

Figure 23: Point-of-Care Diagnostics Market, Germany, Revenue ($m), 2011–2018 35

Figure 24: Clinical Chemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011–2018 36

Figure 25: Immunochemistry PoC Diagnostics Market, Germany, Revenue ($m), 2011–2018 37

Figure 26: Hematology PoC Diagnostics Market, Germany, Revenue ($m), 2011–2018 38

Figure 27: Point-of-Care Diagnostics Market, France, Revenue ($m), 2011–2018 39

Figure 28: Clinical Chemistry PoC Diagnostics Market, France, Revenue ($m), 2011–2018 40

Figure 29: Immunochemistry PoC Diagnostics Market, France, Revenue ($m), 2011–2018 41

Figure 30: Hematology PoC Diagnostics Market, France, Revenue ($m), 2011–2018 42

Figure 31: Point-of-Care Diagnostics Market, Italy, Revenue ($m), 2011–2018 43

Figure 32: Clinical Chemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011–2018 44

Figure 33: Immunochemistry PoC Diagnostics Market, Italy, Revenue ($m), 2011–2018 45

Figure 34: Hematology PoC Diagnostics Market, Italy, Revenue ($m), 2011–2018 46

Figure 35: Point-of-Care Diagnostics Market, Spain, Revenue ($m), 2011–2018 47

Figure 36: Clinical Chemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011–2018 48

Figure 37: Immunochemistry PoC Diagnostics Market, Spain, Revenue ($m), 2011–2018 49

Figure 38: Hematology PoC Diagnostics Market, Spain, Revenue ($m), 2011–2018 50

Figure 39: Point-of-Care Diagnostics Market, Japan, Revenue ($m), 2011–2018 51

Figure 40: Clinical Chemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011–2018 52

Figure 41: Immunochemistry PoC Diagnostics Market, Japan, Revenue ($m), 2011–2018 53

Figure 42: Hematology PoC Diagnostics Market, Japan, Revenue ($m), 2011–2018 54

Figure 43: Point-of-Care Diagnostics Market, Global, Key Company Share (%), 2011 55

Figure 44: Point-of-Care Diagnostics, Market Opportunities and Risk Evaluation 56

Figure 45: Alere, Internal Factors Evaluation 59

Figure 46: Roche, Internal Factors Evaluation 63

Figure 47: Siemens Healthcare Diagnostics, Internal Factors Evaluation 66

Figure 48: Abbott Diagnostics, Internal Factors Evaluation 68

Figure 49: Pipeline Technology Assessment for PoC Diagnostics, Global, by Development Stage 71